References
- Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551–5
- Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A 1995; 92: 12146–50
- Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature 1999; 401: 297–300
- Bukholm IR, Bukholm G, Nesland JM. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 2001; 93: 283–7
- Masaki T, Shiratori Y, Rengifo W. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003; 37: 534–43
- Chen HM, Yen-Ping Kuo M, Lin KH, Lin CY, Chiang CP. Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol 2003; 39: 476–82
- Muller-Tidow C, Bornemann C, Diederichs S. Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology. FEBS Lett 2001; 490: 75–8
- Dong Y, Sui L, Tai Y, Sugimoto K, Hirao T, Tokuda M. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clin Cancer Res 2000; 6: 4253–8
- Nguyen DC, Parsa B, Close A. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 2003; 22: 1285–90
- Keyomarsi K, Tucker SL, Buchholz TA. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347: 1566–75
- Li JQ, Miki H, Wu F. Cyclin A correlates with carcinogenesis and metastasis, and p27kip1 correlates with lymphatic invasion, in colorectal neoplasm. Hum Pathol 2002; 33: 1006–15
- Del-Pizzo JJ, Borkowski A, Jacobs SC, Kyprianou N. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 1999; 155: 1129–36
- Akli S, Zheng PJ, Multani AS. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 2004; 64: 3198–208
- Nielsen NH, Emdin SO, Cajander J, Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997; 14: 295–304
- Zindy F, Lamas E, Chenivesse X. Cyclin A is required in normal epithelial cells. Biochem Biophys Res Commun 1992; 182: 1144–54
- Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68: 67–108
- Hanson KD, Shichiri M, Follansbee MR, Sedivy JM. Effects of c-myc expression on cell cycle progression. Mol Cell Biol 1994; 14: 5748–5755
- Cho NH, Kim YT, Kim JW. Correlation between G1 cyclins and HPV in uterine cervix. Int J Gynecol Pathol 1997; 16: 339–47
- Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 1996; 10: 1979–90
- Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 1999; 13: 2375–87
- Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Aberrant expression of cyclin A in laryngeal squamous cell carcinoma. Anticancer Res 2002; 22: 83–90